A specialized selection of active angel investor networks and syndicates in the Silicon Valley ecosystem that focus heavily on biotechnology, life sciences, and deep tech startups. These groups provide not only critical seed funding but also strategic guidance, regulatory expertise, and access to key healthcare industry partners.
Get targeted exposure with custom position pinning and highlighted placement.
A prominent network exclusively dedicated to early-stage biotech and life science companies. Members include successful entrepreneurs, executives, and investors who provide capital along with deep scientific and commercial mentorship to help startups navigate the complex R&D landscape.
A dedicated angel investment group focused on supporting early-stage biotechnology ventures within the San Francisco Bay Area. They offer structured due diligence processes and access to a broad network of industry veterans who understand the specific risks and rewards of drug discovery and development.
A global network with strong ties to Silicon Valley that connects early-stage bio and pharma companies with accredited investors. The group focuses on providing seed funding and strategic advice to founders developing innovative therapies, devices, and diagnostics.
One of the largest angel investment groups in the world, with a significant portion of its deal flow originating from the biotech and health tech sectors. They provide not just capital but also hands-on support through their mentorship programs and extensive corporate partner network.
While covering a broader region, this network has a strong presence in Southern California and Silicon Valley with specific sub-groups focused on life sciences. They facilitate group investment rounds and offer valuable resources for early-stage startups seeking to validate their business models.
A specialized syndicate that aggregates capital from high-net-worth individuals with a focus on life science innovations. They are known for their rigorous screening process and provide startups with access to a curated list of experts in regulatory affairs and clinical development.
A highly active angel group in the heart of Silicon Valley that frequently invests in health tech and biotech innovations. Their investment committee includes seasoned professionals from major pharmaceutical and biotech firms, offering strategic value beyond financial capital.
A leading angel group that invests in diverse sectors but has a notable track record in biotech and digital health. They provide support during the critical seed stage, helping founders build scalable business models and connect with necessary industry partners for growth.
A network specifically targeted at investors and entrepreneurs in the intersection of technology and healthcare. They focus on early-stage startups developing innovative solutions in diagnostics, therapeutics, and digital health platforms, offering tailored mentorship from industry leaders.
Part of the BioEnterprise ecosystem in Columbus but with connections to Silicon Valley networks, this group focuses on early-stage biotech. They provide investment and operational support to help companies move from lab to market, leveraging a strong regional and national network.
While based in the UK, this network has significant cross-Atlantic investments and partnerships with Silicon Valley firms. They have a strong life sciences focus and often participate in syndicates with US-based investors, providing global perspective and access to European markets for biotech startups.
A German-based angel network with growing ties to the US biotech scene. They invest in innovative life science ventures and often collaborate with Silicon Valley groups, offering startups access to both European and American investor pools and regulatory expertise.
Not a single network, but a platform where top Silicon Valley angel investors form syndicates specifically for life science deals. Founders can find active syndicates led by reputable angels who pool capital and expertise for early-stage biotech investments.
A venture capital firm that often operates like an angel syndicate in its earliest rounds, with a heavy focus on biotech and life sciences. They provide extensive post-investment support through their First Round Review and hands-on partnership model for early-stage founders.
A life sciences venture capital firm with deep roots in Boston and Silicon Valley. While primarily a VC firm, they often engage in early-stage angel-like investments and partnerships, providing unparalleled scientific and business mentorship to biotech startups.
A venture philanthropy company that builds and scales life sciences companies. They offer a unique model where they provide initial funding and resources to founders in their inception phase, effectively acting as an institutional angel investor with deep operational support.
While a general startup accelerator, Y Combinator has specific batches and programs for life sciences. They provide seed funding and rigorous mentorship, helping biotech founders validate their business models and connect with specialized angel investors and VCs in the health sector.
A non-profit accelerator with a strong presence in Silicon Valley that offers a dedicated life science program. They provide no-equity seed funding, mentorship, and access to a vast network of investors, including angels focused on biotech and health tech innovations.
A specialized life sciences accelerator that provides seed funding, lab space, and mentorship to early-stage startups. With locations in Silicon Valley and other hubs, they attract a network of angel investors and VCs who are specifically interested in bio-based innovations.
An early-stage venture fund with a strong focus on consumer tech and life sciences. They invest in seed-stage biotech startups and provide strategic guidance, connecting founders with their network of angels and industry experts to accelerate product development and market entry.
A leading venture capital firm with a dedicated bio and health fund that invests at all stages, including early rounds. They provide unparalleled operational support, regulatory expertise, and access to a vast network of angel investors and corporate partners in the biotech space.